RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
RETA
Delisted
RETA was delisted on the 25th of September, 2023.
2 hedge funds and large institutions have $2.98M invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 210 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2
Holders Change
-212
Holders Change %
-99.07%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
210
Calls
$16.5M
Puts
$50.7M
Net Calls
-$34.3M
Net Calls Change
-$53.4M
Top Buyers
No buyers this quarter
